KIYATEC: Funding, Investors & Team (Sep 2026)
KIYATEC utilizes the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies. Its 3DKUBE technology platform conveniently and cost-effectively incorporates perfusion flow, accommodates all scaffold materials, allows in situ imaging, models complex human biology using segregated cell co‐culture, and is a single-use disposable. 3DKUBE cell‐based assays leverage these features to create better in vitro prediction of complex biochemical responses in humans, with a focus on the evaluation of drug toxicity and efficacy prior to use in human clinical trials.
KIYATEC has raised $18.0M across 2 funding rounds on record, the most recent an undisclosed round announced in May 2023.
KIYATEC Company Profile and Key Stats
Latest funding round on record: May 2023.
KIYATEC Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
KIYATEC raised $18.0M in a Series C announced in Dec 2022.
5 months later, an undisclosed round was announced in May 2023 with no disclosed amount.
KIYATEC Founders and Leadership Team
No contact details are on record for this team yet.
KIYATEC Funding Compared to Other Biotechnology Startups
Funded Startups Like KIYATEC in Biotechnology and Greenville
Companies Similar to KIYATEC
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
KIYATEC Funding FAQs
What does KIYATEC do?
KIYATEC utilizes the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies. Its 3DKUBE technology platform conveniently and cost-effectively incorporates perfusion flow, accommodates all scaffold materials, allows in situ imaging, models complex human biology using segregated cell co‐culture, and is a single-use disposable. 3DKUBE cell‐based assays leverage these features to create better in vitro prediction of complex biochemical responses in humans, with a focus on the evaluation of drug toxicity and efficacy prior to use in human clinical trials.
How much funding has KIYATEC raised?
KIYATEC has raised $18.0M across 2 rounds on record.
When did KIYATEC last raise funding?
KIYATEC's most recent funding round on record was announced in May 2023. The amount was not disclosed.
Who is the CEO of KIYATEC?
Matthew R Gevaert is listed as CEO at KIYATEC.
Where is KIYATEC headquartered?
KIYATEC is based in Greenville, South Carolina, United States.
How many employees does KIYATEC have?
KIYATEC is in the 11-50 employee band.
About FundedIQ's KIYATEC Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for KIYATEC is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.